Stanford University Medical Center Division of Hematology — Stanford, California

Stanford University Medical Center Division of Hematology is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford University Medical Center Division of Hematology has participated in 5 clinical trials.

Therapeutic areas: Paroxysmal Hemoglobinuria, Nocturnal, Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma.

Sponsors: Alexion Pharmaceuticals, Inc., Novartis Pharmaceuticals, Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

• Stanford University School of Med /ID# 236922
• Stanford Hospitals and Clinics
• Stanford University School of Med /ID# 242809
• Stanford University School of Medicine; Stanford Hospital Pharmacy
• Stanford hospital & Clinics; Investigational Drug Services
• Stanford University Medical School
• Stanford University Medical Center Stanford Comprehensive Cancer Center
• Stanford Medical Center and Lucile Packard Children's Hospital
• Stanfor University
• Stanford University Department of Pediatric Endocrinology
• Stanford University Medical Center Stanford
• University of Stanford Medical Center

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Medical Center Division of Hematology?

Stanford University Medical Center Division of Hematology has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Medical Center Division of Hematology conducted?

Stanford University Medical Center Division of Hematology has 5 clinical trials on record. Their work covers Paroxysmal Hemoglobinuria, Nocturnal, Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma.

Is Stanford University Medical Center Division of Hematology accredited by Crixeo Clinical Trials?

Stanford University Medical Center Division of Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Medical Center Division of Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.